XENOVA RES LTD has a total of 44 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are GLAXOSMITHKLINE BIOLOGICALS SA, GLAXOSMITHKLINE BIOLOG S and GLOBEIMMUNE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 2 | |
#6 | Hong Kong | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Brazil | 1 | |
#9 | United Kingdom | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Powers Stephen P | 28 |
#2 | Greenstein Julia L | 28 |
#3 | Exley Mark A | 28 |
#4 | Fox Barbara S | 27 |
#5 | Swain Philip A | 25 |
#6 | Gefter Malcolm L | 24 |
#7 | Schad Victoria C | 21 |
#8 | Briner Thomas J | 9 |
#9 | Hickling Julian Kingdon | 4 |
#10 | Offringa Rienk | 4 |
Publication | Filing date | Title |
---|---|---|
US2004241190A1 | Vaccine preparations | |
US2003224502A1 | Recovery of virus from cell culture using a hypertonic salt solution | |
GB0308691D0 | Vaccine preparations | |
US2002102536A1 | Preparation of human or animal herpesviruses | |
AU4888100A | Hapten-carrier conjugates for use in drug-abuse therapy | |
CA2588767A1 | Hapten-carrier conjugates for use in drug-abuse therapy | |
EP0814843A2 | Hapten-carrier conjugates for use in drug-abuse therapy | |
US7374768B1 | Viral vaccines |